Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro

Thrombosis and Haemostasis

Volumn 94, Issue 6, 2005, Pages 1257-1264

  Van Leer, Coretta ^a   Stutz, Monika ^a   Haeberli, André ^a   Geiser, Thomas ^a  

^a PSI   (Switzerland)

Author keywords

Alveolar epithelial repair; Fibrin; Fibrinolysis; Pulmonary fibrosis; uPA

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTIFIBRINOLYTIC AGENT; CYTOKINE; D DIMER; FIBRIN; FRUCTOSE BISPHOSPHATE; INTERLEUKIN 1BETA; NEUTRALIZING ANTIBODY; PLASMIN; TRANEXAMIC ACID; UROKINASE;

ARTICLE; CELL CULTURE; CELL MIGRATION; CELL REGENERATION; CELL SPREADING; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; FIBRINOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; PRIORITY JOURNAL; REGULATORY MECHANISM; SUPERNATANT; WOUND HEALING;

ANTIBODIES; ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL SHAPE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; INTERLEUKIN-1; PULMONARY ALVEOLI; PULMONARY FIBROSIS; TIME FACTORS; TRANEXAMIC ACID; URINARY PLASMINOGEN ACTIVATOR; WOUND HEALING;

EID: 29244483676     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-03-0162     Document Type: Article

References (35)

1. Loskutoff DJ, Quigley JP. PAI-1, fibrosis, and the elusive provisional fibrin matrix. J Clin Invest 2000; 106: 1441-3.
2. Selman M, Pardo A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res 2002; 3: 3.
3. Adamson IY, Young L, Bowden DH. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 1988; 130: 377-83.
4. Geiser T. Idiopathic pulmonary fibrosis - a disorder of alveolar wound repair? Swiss Med Wkly 2003; 133: 405-11.
5. Clark RA, Lanigan JM, DellaPelle P et al. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982; 79: 264-9.
6. Grinnell F et al. Fibroblast adhesion to fibrinogen and fibrin substrata: requirement for cold-insoluble globulin (plasma fibronectin). Cell 1980; 19: 517-25.
7. Fuchs-Buder T et al. Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 153: 163-7.
8. Gunther A, Mosavi P, Heinemann S et al. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 161: 454-62.
9. Chapman HA, Allen CL, Stone OL. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am Rev Respir Dis 1986; 133: 437-43.
10. Kotani I et al. Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb Res 1995; 77: 493-504.
11. Bertozzi P et al. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 1990; 322: 890-7.
12. Barazzone C, Belin D, Piguet PF et al. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. J Clin Invest 1996; 98: 2666-73.
13. Pinsky DJ, Liao H, Lawson CA et al. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J Clin Invest 1998; 102: 919-28.
14. Idell S et al. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition. Am J Pathol 1989; 135: 387-99.
15. Sitrin RG et al. Tissue fibrin deposition during acute lung injury in rabbits and its relationship to local expression of procoagulant and fibrinolytic activities. Am Rev Respir Dis 1987; 135: 930-6.
16. Eitzman DT, McCoy RD, Zheng X et al. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the marine plasminogen activator inhibitor-1 gene. J Clin Invest 1996; 97: 232-7.
17. Simon RH, Gross TJ, Edwards JA et al. Fibrin degradation by rat pulmonary alveolar epithelial cells. Am J Physiol 1992; 262: L482-8.
18. Hasegawa T, Sorensen L, Dohi M et al. Induction of urokinase-type plasminogen activator receptor by IL-1β. Am J Respir Cell Mol Biol 1997; 16: 683-92.
19. Hattori N, Sisson TH, Xu Y et al. Upregulation of fibrinolysis by adenovirus-mediated transfer of urokinase-type plasminogen activator genes to lung cells in vitro and in vivo. Hum Gene Ther 1999; 10: 215-22.
20. Gross TJ et al. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase. Am J Physiol 1991; 260: L286-95.
21. Geiser T, Jarreau PH, Atabai K et al. Interleukin-1beta augments in vitro alveolar epithelial repair. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1184-90.
22. Kiama SG et al. A scanning electron microscope study of the luminal surface specializations in the blood vessels of the pecten oculi in a diurnal bird, the black kite (Milvus migrans). Ann Anat 1998; 180: 455-60.
23. Geiser T et al. Pulmonary edema fluid from patients with acute lung injury augments in vitro alveolar epithelial repair by an IL-1β-dependent mechanism. Am J Respir Crit Care Med 2001; 163: 1384-8.
24. Pugin J, Ricou B, Steinberg KP et al. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 1996; 153: 1850-6.
25. Marshall BC, Xu QP, Rao NV et al. Pulmonary epithelial cell urokinase-type plasminogen activator. Induction by interleukin-1 beta and tumor necrosis factor-alpha. J Biol Chem 1992; 267: 11462-9.
26. Spencer H. Interstitial pneumonia. Annu Rev Med 1967; 18: 423-42.
27. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003; 31(4 Suppl): S213-20.
28. Sedo A, Mandys V, Krepela E. Cell membrane-bound proteases: not "only" proteolysis. Physiol Res 1996; 45: 169-76.
29. Hornebeck W et al. Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol 2002; 12: 231-41.
30. Alfano D et al. The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis. Thromb Haemost 2005; 93: 205-11.
31. Bass R, Ellis V. Cellular mechanisms regulating non-haemostatic plasmin generation. Biochem Soc Trans 2002; 30: 189-94.
32. Lijnen HR. Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry (Mosc) 2002; 67: 92-8.
33. Friedl P, Wolf K. Proteolytic and non-proteolytic migration of tumour cells and leucocytes. Biochem Soc Symp 2003: 277-85.
34. Romer J, Bugge TH, Pyke C et al. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 1996; 2: 287-92.
35. Planus E, Galiacy S, Matthay M et al. Role of collagenase in mediating in vitro alveolar epithelial wound repair. J Cell Sci 1999; 112: 243-52.